Cargando…

In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis

PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamakh-Ayari, Rym, Bras-Gonçalves, Rachel, Bahi-Jaber, Narges, Petitdidier, Elodie, Markikou-Ouni, Wafa, Aoun, Karim, Moreno, Javier, Carrillo, Eugenia, Salotra, Poonam, Kaushal, Himanshu, Negi, Narender Singh, Arevalo, Jorge, Falconi-Agapito, Francesca, Privat, Angela, Cruz, Maria, Pagniez, Julie, Papierok, Gérard-Marie, Rhouma, Faten Bel Haj, Torres, Pilar, Lemesre, Jean-Loup, Chenik, Mehdi, Meddeb-Garnaoui, Amel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008367/
https://www.ncbi.nlm.nih.gov/pubmed/24786587
http://dx.doi.org/10.1371/journal.pone.0092708
_version_ 1782314432486965248
author Chamakh-Ayari, Rym
Bras-Gonçalves, Rachel
Bahi-Jaber, Narges
Petitdidier, Elodie
Markikou-Ouni, Wafa
Aoun, Karim
Moreno, Javier
Carrillo, Eugenia
Salotra, Poonam
Kaushal, Himanshu
Negi, Narender Singh
Arevalo, Jorge
Falconi-Agapito, Francesca
Privat, Angela
Cruz, Maria
Pagniez, Julie
Papierok, Gérard-Marie
Rhouma, Faten Bel Haj
Torres, Pilar
Lemesre, Jean-Loup
Chenik, Mehdi
Meddeb-Garnaoui, Amel
author_facet Chamakh-Ayari, Rym
Bras-Gonçalves, Rachel
Bahi-Jaber, Narges
Petitdidier, Elodie
Markikou-Ouni, Wafa
Aoun, Karim
Moreno, Javier
Carrillo, Eugenia
Salotra, Poonam
Kaushal, Himanshu
Negi, Narender Singh
Arevalo, Jorge
Falconi-Agapito, Francesca
Privat, Angela
Cruz, Maria
Pagniez, Julie
Papierok, Gérard-Marie
Rhouma, Faten Bel Haj
Torres, Pilar
Lemesre, Jean-Loup
Chenik, Mehdi
Meddeb-Garnaoui, Amel
author_sort Chamakh-Ayari, Rym
collection PubMed
description PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection.
format Online
Article
Text
id pubmed-4008367
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40083672014-05-09 In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis Chamakh-Ayari, Rym Bras-Gonçalves, Rachel Bahi-Jaber, Narges Petitdidier, Elodie Markikou-Ouni, Wafa Aoun, Karim Moreno, Javier Carrillo, Eugenia Salotra, Poonam Kaushal, Himanshu Negi, Narender Singh Arevalo, Jorge Falconi-Agapito, Francesca Privat, Angela Cruz, Maria Pagniez, Julie Papierok, Gérard-Marie Rhouma, Faten Bel Haj Torres, Pilar Lemesre, Jean-Loup Chenik, Mehdi Meddeb-Garnaoui, Amel PLoS One Research Article PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection. Public Library of Science 2014-05-02 /pmc/articles/PMC4008367/ /pubmed/24786587 http://dx.doi.org/10.1371/journal.pone.0092708 Text en © 2014 Chamakh-Ayari et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chamakh-Ayari, Rym
Bras-Gonçalves, Rachel
Bahi-Jaber, Narges
Petitdidier, Elodie
Markikou-Ouni, Wafa
Aoun, Karim
Moreno, Javier
Carrillo, Eugenia
Salotra, Poonam
Kaushal, Himanshu
Negi, Narender Singh
Arevalo, Jorge
Falconi-Agapito, Francesca
Privat, Angela
Cruz, Maria
Pagniez, Julie
Papierok, Gérard-Marie
Rhouma, Faten Bel Haj
Torres, Pilar
Lemesre, Jean-Loup
Chenik, Mehdi
Meddeb-Garnaoui, Amel
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title_full In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title_fullStr In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title_full_unstemmed In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title_short In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
title_sort in vitro evaluation of a soluble leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008367/
https://www.ncbi.nlm.nih.gov/pubmed/24786587
http://dx.doi.org/10.1371/journal.pone.0092708
work_keys_str_mv AT chamakhayarirym invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT brasgoncalvesrachel invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT bahijabernarges invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT petitdidierelodie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT markikououniwafa invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT aounkarim invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT morenojavier invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT carrilloeugenia invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT salotrapoonam invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT kaushalhimanshu invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT neginarendersingh invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT arevalojorge invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT falconiagapitofrancesca invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT privatangela invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT cruzmaria invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT pagniezjulie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT papierokgerardmarie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT rhoumafatenbelhaj invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT torrespilar invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT lemesrejeanloup invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT chenikmehdi invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis
AT meddebgarnaouiamel invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis